Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration

European Journal of Pharmacology

Volumn 398, Issue 1, 2000, Pages 11-18

  Burrows, Kristan B ^a   Gudelsky, Gary ^b   Yamamoto, Bryan K ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Amphetamine; Cytochrome oxidase; Energy metabolism; Histochemistry; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CYTOCHROME C OXIDASE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; ENERGY METABOLISM; ENZYME ACTIVITY; MALE; MITOCHONDRION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SUBSTANTIA NIGRA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BODY TEMPERATURE; BRAIN; BRAIN MAPPING; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX IV; MALE; METHAMPHETAMINE; MITOCHONDRIA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0034625498     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00264-8     Document Type: Article

References (42)

1. Abekawa T., Ohmori T., Koyama T. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain. J. Neural Trans. 103(6):1996;671-680.
2. Allen R., McCann U., Ricaurte G. Persistent effects of (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. Sleep. 16(6):1993;560-564.
3. Ben-Schachar D., Zuk R., Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64:1995;718-723.
4. Berman S.B., Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73(3):1999;1127-1137.
5. Bolla K., McCann U., Ricaurte G. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology. 51:1998;1532-1537.
6. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268(3):1994;1571-1580.
7. Burrows K.B., Nixdorf W.L., Yamamoto B.K. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. J. Pharmacol. Exp. Ther. 292(3):2000;853-860.
8. Chan P., Di Monte D.A., Luo J.J., DeLanney L.E., Irwin I., Langston J.W. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62:1994;2484-2487.
9. Che S., Johnson M., Hanson G.R., Gibb J.W. Body temperature effects on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur. J. Pharmacol. 293:1995;447-453.
10. Cleeter M.W., Cleeter J.M., Cleeter C., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345(1):1994;50-54.
11. Craig A.L., Kupferberg H.J. Hyperthermia in D-amphetamine toxicity in aggregated mice of different strains. J. Pharmacol. Exp. Ther. 180:1972;616-624.
12. Erecinska M., Silver I. ATP and brain function. J. Cereb. Blood Flow Metab. 9:1989;2-19.
13. Graham D.G., Tiffany S.M., Bell W.B., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxy dopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
14. Hevner R., Duff R., Wong-Riley M. Coordination of ATP production and consumption in brain: parallel regulation of cytochrome oxidase and Na+, K+-ATPase. Neurosci. Lett. 138:1992;188-192.
15. Hevner R.F., Liu S., Wong-Riley M.T. A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience. 65(2):1995;313-342.
16. Huang Y.H., Tsai S.J., Su T.W., Sim C.B. Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats. Neuropsychopharmacology. 21(3):1999;427-434.
17. Huether G., Zhou D., Ruther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. J. Neural Trans. 104:1997;771-794.
18. Jiang X., Wrona M., Dryhurst G. Tryptamine-4,5-dione, a putative endotoxic metabolite of the superoxide-mediated oxidation of serotonin, is a mitochondrial toxin: possible implications in neurodegenerative disorders. Chem. Res. Toxicol. 12:1999;429-436.
19. Kageyama G., Wong-Riley M. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience. 7:1982;2337-2361.
20. Lizasoain I., Moro M.A., Knowles R.G., Darley-Usmar V., Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314(3):1996;877-880.
21. McBean D.E., Sharkey J., Ritchie I.M., Kelly P.A. Chronic effects of the selective serotoninergic neurotoxin, methylenedioxyamphetamine, upon cerebral function. Neuroscience. 38(1):1990;271-275.
22. McCann U., Szabo Z., Scheffel U., Dannals R., Ricaurte G. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet. 352:1998;1433-1437.
23. McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18(20):1998;8417-8422.
24. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70:1998;2406-2415.
25. Mjaatvedt A., Wong-Riley M. Effects of unilateral climbing fibre deafferentation on cytochrome oxidase activity in the developing rat cerebellum. J. Neurocytol. 20:1991;2-16.
26. Morgan M. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology. 141:1999;30-36.
27. Pardo B., Mena M.A., de Yebenes J.G. L-DOPA inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastome NB69 cells. J. Neurochem. 64(2):1995;576-582.
28. Poblete J., Azmitia E. Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor. Brain Res. 680(1-2):1995;9-15.
29. Pontieri F.E., Crane A.M., Seiden L.S., Kleven M.S., Porrino L.J. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology. 102(2):1990;175-182.
30. Porrino L.J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res. 307(1-2):1984;311-320.
31. Shankaran M., Yamamoto B., Gudelsky G. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. J. Neurochem. 72:1999;2516-2522.
32. Sharkey J., McBean D.E., Kelly P.A. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Psychopharmacology. 105(1):1991;113-118.
33. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse. 17:1994;203-209.
34. Stephans S.E., Whittingham T.S., Douglas A.J., Lust W.D., Yamamoto B.K. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J. Neurochem. 71:1998;613-621.
35. Wan F.J., Lin H.C., Kang B.H., Tseng C.J., Tung C.S. D-Amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res. Bull. 50(3):1999;167-171.
36. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2(6):1996;699-703.
37. Wong-Riley M. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171:1979;11-28.
38. Wong-Riley M. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12(3):1989;94-101.
39. Yagi T., Hatefi Y. Thiols in oxidative phosphorylation: thiols in the F0 of ATP synthase essential for ATPase activity. Arch. Biochem. Biophy. 254(1):1987;102-109.
40. Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287(1):1998;107-114.
41. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265(27):1990;16330-16336.
42. Zheng Y., Laverty R. Role of brain nitric oxide in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Brain Res. 795:1998;257-263.